Genmab — Juni 2019
-
Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38 https://www.einnews.com/pr_news/488236772/molecular-templates-announces-fda-acceptance-of-ind-application-for-tak-169-an-engineered-toxin-body-targeting-cd38
-
Helt ærligt --- ? --- nej

-
Det er vel kun om behandlingen bliver SOC?
-
Selv selveste S. Vincent Rajkumar udtalte for et par år siden i Weekend (eller refereret), "jeg er imponeret over gruppens data, og det er den største enkeltstående effekt, vi har set fra et lægemiddel mod MM i 50-60 år". Det var Dara han talte om. MAIA skal nok køre fint hjem.
-
1188,5
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind